Related Experiment Videos
[Treatment of congestive heart failure using angiotensin I convertase inhibitors]
1Nemocnica s poliklinikou Podborany.
Insights
Angiotensin-converting enzyme (ACE) inhibitors effectively treat heart failure. A patient with ischemic heart disease and frequent decompensation relapses experienced rapid symptom normalization and improved functional status after starting an ACE inhibitor.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Ischemic heart disease (IHD) can lead to chronic heart failure and recurrent circulatory decompensation.
- Standard treatments including diuretics and cardiotonics may not always prevent frequent relapses in advanced stages.
Observation:
- A 70-year-old female patient with IHD and sick-sinus syndrome, despite pacemaker implantation and conventional therapy, experienced persistent global decompensation.
- The patient suffered from frequent relapses, indicating suboptimal management with existing treatments.
Findings:
- Administration of an angiotensin-converting enzyme (ACE) inhibitor, Tensiomin, resulted in rapid (days) normalization of congestion indicators.
- Following treatment, the patient showed no further relapses of decompensation during follow-up.
Implications:
- ACE inhibitors represent a highly effective therapeutic option for managing refractory heart failure in patients with IHD.
- This case highlights the potential for ACE inhibitors to significantly improve functional capacity (NYHA class shift from IV to II) and reduce hospitalizations.
Abstract:
The authors describe the case of a 70-year-old female patient with ischaemic heart disease with an implanted pacemaker on account of sick-sinus syndrome, who after classical treatment with diuretics and cardiotonics suffered from frequent relapses of global decompensation of the circulation. After administration of the ACE inhibitor--Tensiomin--within a very short time (days) normalization of all indicators of previously severe congestion was found. During the subsequent follow up no relapse of decompensation occurred. The patient was shifted from stage IV to stage II in the functional classification of ischaemic heart disease according to NYHA.